Article

Inhibition of Bruton’s tyrosine kinase reduces NF-kB and NLRP3 inflammasome activity…

medRxiv · 2019 · Gareth S. D. Purvis

Key facts

Title Inhibition of Bruton’s tyrosine kinase reduces NF-kB and NLRP3 inflammasome activity preventing insulin resistance and microvascular disease
First author Gareth S. D. Purvis
Journal medRxiv
Published Aug 28, 2019
DOI 10.1101/745943
Devices mentioned K103302, K213883, K233027, K912666
Product codes mentioned JCJ, KIP, KIT, MVU, NDS, NJT, OOI, PSY, LIQ

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature